BNC Chosen by Saudi Arabian Research Institution in Multi-Million Pound Environmental Nanotechnology Project
News Oct 20, 2009
The specialist product development consultancy, Bio Nano Consulting (BNC) has announced that it has been chosen to lead the UK arm of a collaboration with a major research institution in the Middle East in a multi-million pound environmental nanotechnology endeavor.
The agreement, worth in excess of £2 million over two years for BNC and its London partners, will utilize the expertise of the London Centre for Nanotechnology (LCN), a joint venture between Imperial College and University College London, on two important projects looking at the applications of nanotechnology to environmental issues: ‘nano-catalysts for wastewater treatment’ and ‘nano-catalysts for the synthesis of fine chemicals’.
Solar energy can be harnessed to oxidize pollutants and facilitate the successful recycling of waste water. For this project, BNC will provide extensive knowledge of nano structure development in solar cells and nanometrology, to complement the in-house catalysis and characterization expertise of its collaborator in the Middle East.
BNC will also provide access to the nanotechnology facilities at the LCN for the development of environmentally-friendly heterogeneous catalysts in the second project. Many current chemical synthesis processes rely on homogenous catalysts in the liquid phase; as a result, a lack of catalyst regeneration, side reactions and salt formation cause problems with effective waste disposal. The development of heterogeneous nano-catalysts could result in a reduced waste stream, facile separation and reuse of the catalyst.
Delivering a range of services, expertise and equipment to the life-science and technology sectors, BNC is able to address a wide range of real-life problems with nanotechnology-based solutions.
“We are delighted to have secured such a fantastic opportunity to display our expertise in such a large contract” commented Dr David Sarphie, CEO of BNC. He continued, “It is great news that our world-class technology is being recognized and put to use in research that will be of such great benefit to the environment.”
Novel Chemistry Technique Simplifies Late-Stage Modification of Drug CompoundsNews
Chemists at The Scripps Research Institute (TSRI) have invented a technique that overcomes a long-standing problem in organic chemistry and should streamline the process of discovery and development for many new drugs.READ MORE
Elpis BioMed Closes Funding Round to Commercialise Novel Technology Platform for Generating Human Cell TypesNews
New Cambridge spin-out company commercialises disruptive technology that enables rapid generation of pure and consistent batches of human cell types. Geographically diversified, top-tier investor team includes key industry leaders to support early company development.READ MORE
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing OrganizationNews
Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..READ MORE